362 related articles for article (PubMed ID: 28869888)
1. Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies.
Chiaravalli M; Reni M; O'Reilly EM
Cancer Treat Rev; 2017 Nov; 60():32-43. PubMed ID: 28869888
[TBL] [Abstract][Full Text] [Related]
2. New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma.
Singh RR; O'Reilly EM
Drugs; 2020 May; 80(7):647-669. PubMed ID: 32306207
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic Cancer: A Review.
Park W; Chawla A; O'Reilly EM
JAMA; 2021 Sep; 326(9):851-862. PubMed ID: 34547082
[TBL] [Abstract][Full Text] [Related]
4. Management of Metastatic Pancreatic Adenocarcinoma.
Cheema AR; O'Reilly EM
Surg Clin North Am; 2016 Dec; 96(6):1391-1414. PubMed ID: 27865284
[TBL] [Abstract][Full Text] [Related]
5. Addressing the challenges of pancreatic cancer: future directions for improving outcomes.
Hidalgo M; Cascinu S; Kleeff J; Labianca R; Löhr JM; Neoptolemos J; Real FX; Van Laethem JL; Heinemann V
Pancreatology; 2015; 15(1):8-18. PubMed ID: 25547205
[TBL] [Abstract][Full Text] [Related]
6. Metastatic pancreatic ductal adenocarcinoma: diagnosis and treatment with a view to the future.
Pokorny AMJ; Chin VT; Nagrial AM; Yip D; Chantrill LA
Intern Med J; 2018 Jun; 48(6):637-644. PubMed ID: 29898269
[TBL] [Abstract][Full Text] [Related]
7. Perspectives in the treatment of pancreatic adenocarcinoma.
Cid-Arregui A; Juarez V
World J Gastroenterol; 2015 Aug; 21(31):9297-316. PubMed ID: 26309356
[TBL] [Abstract][Full Text] [Related]
8. State of the art and future directions of pancreatic ductal adenocarcinoma therapy.
Neuzillet C; Tijeras-Raballand A; Bourget P; Cros J; Couvelard A; Sauvanet A; Vullierme MP; Tournigand C; Hammel P
Pharmacol Ther; 2015 Nov; 155():80-104. PubMed ID: 26299994
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies.
Adamska A; Domenichini A; Falasca M
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640192
[TBL] [Abstract][Full Text] [Related]
10. TTD consensus document on the diagnosis and management of exocrine pancreatic cancer.
Benavides M; Abad A; Ales I; Carrato A; Díaz Rubio E; Gallego J; García-Foncillas J; Grávalos C; Laquente B; Pericay C; Rivera F; Tabernero J; Aranda E
Clin Transl Oncol; 2014 Oct; 16(10):865-78. PubMed ID: 24728654
[TBL] [Abstract][Full Text] [Related]
11. Update on the management of pancreatic cancer: surgery is not enough.
Ansari D; Gustafsson A; Andersson R
World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920
[TBL] [Abstract][Full Text] [Related]
12. Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas.
Hidalgo M; Von Hoff DD
Clin Cancer Res; 2012 Aug; 18(16):4249-56. PubMed ID: 22896691
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapeutic strategies for treating pancreatic cancer: advances and challenges.
Diab M; Azmi A; Mohammad R; Philip PA
Expert Opin Pharmacother; 2019 Apr; 20(5):535-546. PubMed ID: 30592647
[TBL] [Abstract][Full Text] [Related]
14. PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer.
Douglas JE; Liu S; Ma J; Wolff RA; Pant S; Maitra A; Tamm EP; Bhosale P; Katz MHG; Varadhachary GR; Koay EJ
BMC Cancer; 2022 Jan; 22(1):14. PubMed ID: 34980020
[TBL] [Abstract][Full Text] [Related]
15. Smarter drugs emerging in pancreatic cancer therapy.
Kleger A; Perkhofer L; Seufferlein T
Ann Oncol; 2014 Jul; 25(7):1260-1270. PubMed ID: 24631947
[TBL] [Abstract][Full Text] [Related]
16. Pancreas cancer: Therapeutic trials in metastatic disease.
Smithy JW; O'Reilly EM
J Surg Oncol; 2021 May; 123(6):1475-1488. PubMed ID: 33831245
[TBL] [Abstract][Full Text] [Related]
17. Results from the prospective German TPK clinical cohort study: Treatment algorithms and survival of 1,174 patients with locally advanced, inoperable, or metastatic pancreatic ductal adenocarcinoma.
Hegewisch-Becker S; Aldaoud A; Wolf T; Krammer-Steiner B; Linde H; Scheiner-Sparna R; Hamm D; Jänicke M; Marschner N;
Int J Cancer; 2019 Mar; 144(5):981-990. PubMed ID: 30006989
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer: from state-of-the-art treatments to promising novel therapies.
Garrido-Laguna I; Hidalgo M
Nat Rev Clin Oncol; 2015 Jun; 12(6):319-34. PubMed ID: 25824606
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for pancreatic cancer.
Springfeld C; Jäger D; Büchler MW; Strobel O; Hackert T; Palmer DH; Neoptolemos JP
Presse Med; 2019 Mar; 48(3 Pt 2):e159-e174. PubMed ID: 30879894
[TBL] [Abstract][Full Text] [Related]
20. Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.
Al Haddad AH; Adrian TE
Expert Opin Investig Drugs; 2014 Nov; 23(11):1499-515. PubMed ID: 25078674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
